Correlation Between Recursion Pharmaceuticals and 649445AC7

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and 649445AC7 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and 649445AC7 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Recursion Pharmaceuticals and New York Community, you can compare the effects of market volatilities on Recursion Pharmaceuticals and 649445AC7 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of 649445AC7. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and 649445AC7.

Diversification Opportunities for Recursion Pharmaceuticals and 649445AC7

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Recursion and 649445AC7 is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and New York Community in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on New York Community and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with 649445AC7. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of New York Community has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and 649445AC7 go up and down completely randomly.

Pair Corralation between Recursion Pharmaceuticals and 649445AC7

Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 2.91 times less return on investment than 649445AC7. In addition to that, Recursion Pharmaceuticals is 3.18 times more volatile than New York Community. It trades about 0.02 of its total potential returns per unit of risk. New York Community is currently generating about 0.14 per unit of volatility. If you would invest  9,288  in New York Community on September 13, 2024 and sell it today you would earn a total of  409.00  from holding New York Community or generate 4.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy63.64%
ValuesDaily Returns

Recursion Pharmaceuticals  vs.  New York Community

 Performance 
       Timeline  
Recursion Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
New York Community 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in New York Community are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, 649445AC7 may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Recursion Pharmaceuticals and 649445AC7 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Recursion Pharmaceuticals and 649445AC7

The main advantage of trading using opposite Recursion Pharmaceuticals and 649445AC7 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, 649445AC7 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 649445AC7 will offset losses from the drop in 649445AC7's long position.
The idea behind Recursion Pharmaceuticals and New York Community pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences